UroMems is set to enter the pivotal trial phase with its device for treating stress urinary incontinence (SUI). The company was awarded an investigational device exemption (IDE) from the US Food and ...

Samsung has started rolling out its Android 16 update to Galaxy phones and tablets, with a schedule running through November at least. Here’s when to expect the update on your Galaxy device, and which ...

If you're tempted to use a microcurrent device in your skin care routine, here's what the skin pros have to say. Elizabeth is a contributor to CNET and the The Simple Dollar, where she reviews ...

LineageOS 22.1 based on Android 15 QPR1 is now available for over 100 devices. The latest version of LineageOS brings Android 15 changes as well as a new music player and PDF reader. LineageOS 21 is ...

The big picture: Side-channel attacks are designed to exploit specific types of information leaked by hardware devices, allowing attackers to gain unauthorized access to sensitive or secret data.

Android users beware—a new form of Android malware dubbed Pixnapping has been revealed to the public, and in theory, all current Android devices running Android 13 or newer are vulnerable since "the ...

The LineageOS team has released LineageOS 23.0, bringing Android 16 to over 100 different devices. This release is based on the initial Android 16 release due to Google’s delay in releasing QPR1’s ...

A GitHub Copilot Chat bug let attackers steal private code via prompt injection. Learn how CamoLeak worked and how to defend against AI risks. Image: przemekklos/Envato A critical vulnerability in ...

Community driven content discussing all aspects of software development from DevOps to design patterns. Over the past year, I’ve been helping professionals who’ve found themselves displaced by the AI ...

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Follow Ashley Stewart Every time Ashley publishes a story, you’ll get an alert straight to your inbox!

Micro Interventional Devices Receives FDA Approval of the STTAR-US IDE Pivotal Trial for its MIA™-T Percutaneous Tricuspid Annuloplasty System Micro Interventional Devices (MID), a pioneering company ...